Showing 1041-1050 of 5603 results for "".
Improve Staff Utilization in Your Practice
https://reachmd.com/programs/clinicians-roundtable/improve-staff-utilization-in-your-practice/3479/Using philosophies borrowed from the property management field, Marc Halley, president of Halley Consulting Group, shares with host Dr. Larry Kaskel the key to efficient utilization of the support staff within a medical practice. Mr. Halley highlights the importance of delegation within a well managFirst 5 Minutes®: Empowering Shared Decisions in Lung Cancer Screening
https://reachmd.com/programs/cme/first-5-minutes-empowering-shared-decisions-in-lung-cancer-screening/50985/This episode focuses on improving lung cancer screening and early detection by helping primary care providers recognize eligible and high-risk patients, apply current screening guidelines, and engage patients in clear shared decision-making conversations. Speakers will explore why many patients whoRelapse Management in Multiple Sclerosis: Corticosteroids Remain the Linchpin of Therapies
https://reachmd.com/diseases-diagnoses/ms-immune-disorders/relapse-management-in-multiple-sclerosis-corticosteroids-remain-the-linchpin-of-therapies/32084/Several modalities are available for the treatment of multiple sclerosis relapse, including corticosteroids, intravenous immunoglobulins, and therapeutic apheresis.The Battle of Biostimulators: PLLA vs hyperdilute CaHA
https://reachmd.com/ma-issues-index/july-august-2025/biostimulators-PLLA-vs-HyperdiluteCaHA/36663/Key takeaways from Dr. Kay Durairaj's YoungMD Connect workshopIlluminating AOX Serum from ZO Skin Health
https://reachmd.com/topics/skincare/illuminating-aox-serum-from-zo-skin-health/35200/Practical Perspectives in Myasthenia Gravis #3: Therapeutic Selection and Monitoring Efficacy—Matching Mechanisms to Patients
https://reachmd.com/programs/cme/mg-therapeutic-selection-and-monitoring-efficacy-matching-mechanisms-to-patients/39030/Examine evolving gMG management, from standard therapies to targeted agents, with an emphasis on pediatric care and assessment of treatment response.Women’s Sleep Health – Addressing Gaps in OSA Diagnosis and Treatment Across Life Stages
https://reachmd.com/programs/cme/womens-sleep-health-addressing-gaps-in-osa-diagnosis-and-treatment-across-life-stages/36099/Explore women’s life stage–specific factors in OSA diagnosis and management to improve sleep and cardiometabolic outcomes.Clearing the Brain Fog: Innovations in the Treatment and Management of Hepatic Encephalopathy
https://reachmd.com/programs/cme/Clearing-the-Brain-Fog-Innovations-in-the-Treatment-and-Management-of-Hepatic-Encephalopathy/39047/Explore diagnostic and treatment challenges in patients with hepatic encephalopathy to improve outcomes for your patients.Advancing Bispecific Antibodies Upstream in the Treatment Paradigm of Multiple Myeloma
https://reachmd.com/programs/cme/advancing-bispecific-antibodies-upstream-in-the-treatment-paradigm-of-multiple-myeloma/49263/Review emerging evidence supporting earlier use of bispecific antibodies in multiple myeloma, with a focus on efficacy, safety, and optimizing patient outcomes.Muscarinic Therapies as a Catalyst for Change: Addressing Clinical Inertia in Schizophrenia Care
https://reachmd.com/programs/cme/muscarinic-therapies-as-a-catalyst-for-change-addressing-clinical-inertia-in-schizophrenia-care/37101/Examine muscarinic modulation as an alternative to D2 antagonists for schizophrenia, with insights on dosing, tolerability, and patient selection.